Dr. Ravi S Ananthula

CSO & Executive Director, PharmaDEM Solutions

About

Pharma Now

Bio

Dr. Ravi S. Ananthula is the Chief Scientific Officer at PharmaDEM Solutions, with a distinguished 19-year career in drug discovery, clinical trials, and product development. His significant achievements include contributing to 8 New Drug Applications (NDAs) and over 20 Abbreviated New Drug Applications (ANDAs). Dr. Ananthula has been a driving force in India's digital transformation in pharmaceuticals through his software innovations, SoluDEM and FormDEM. He has played a crucial role in COVID-19 drug repurposing, developed the first nasal peptide delivery system globally, and advanced peptide synthesis projects. His career includes work with prominent companies such as Eli Lilly and Company, Dr. Reddy's Laboratories, and Aragen, across both the USA and India. Dr. Ananthula is also an active member of the international computational chemistry consortium and holds multiple patents and publications.

Professional

Associate Director , Eli Lilly and Company

(June 2020 - June 2022)

Sr. Research Scientist II , Eli Lilly and Company

(November 2018 - June 2020)

Research & Application Scientist , NovaLead Pharma Pvt. Ltd.

(January 2010 - December 2010)

Scientist, Medicinal chemistry & Molecular modelling , GVK BIO

(May 2005 - December 2009)

Associate Principal Scientist, Product development , Dr. Reddy's Laboratories

(January 2014 - June 2016)

badge

Active Contributor

2
Followers
-
Total Articles
102
Total Impressions

Join the Thought Leaders Shaping Pharma's Future

A platform for experts, professionals, and industry enthusiasts to share insights, research, and innovations with a global pharma community.

Thought Leader

Other Similar Thought Leaders

pharma-contributor

Mr. Prashanth Hugar

Founder & Director, IncepBio Private Limited

pharma-contributor

Mr. Amitabha Gangopadhyay

Founder & Director, Green Bark Consulting

Pharma Now

Weekly Pharma insights directly in your inbox

Get most important news delivered to your email inbox